EVANSMED Stock Overview
Evans Medical Plc manufactures, markets, and distributes health products.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Evans Medical Plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₦0.50 |
52 Week High | ₦0 |
52 Week Low | ₦0 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | 0% |
3 Year Change | 0% |
5 Year Change | 0% |
Change since IPO | -51.11% |
Recent News & Updates
Recent updates
Shareholder Returns
EVANSMED | NG Pharmaceuticals | NG Market | |
---|---|---|---|
7D | 0% | 2.7% | -0.4% |
1Y | 0% | 11.4% | 131.4% |
Return vs Industry: EVANSMED underperformed the NG Pharmaceuticals industry which returned 85.1% over the past year.
Return vs Market: EVANSMED underperformed the NG Market which returned 52.6% over the past year.
Price Volatility
EVANSMED volatility | |
---|---|
EVANSMED Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 4.7% |
Market Average Movement | 9.1% |
10% most volatile stocks in NG Market | 12.8% |
10% least volatile stocks in NG Market | 4.1% |
Stable Share Price: EVANSMED has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EVANSMED's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1954 | n/a | n/a |
Evans Medical Plc manufactures, markets, and distributes health products. The company operates in the Over the Counter and Prescriptive segments. Its products include anti-malarials, ant-infectives, anti-asthamatics, anti-histaminics, analgesics, anti-ulcerants, anti-hypertensives, anti-diabetics, cold and cough preparations, erectile dysfunctions, energy supplements, herbal products, haematinics blood forming preparations, prostagladins, vitamins and minerals, topical preparations, and pharyngeals.
Evans Medical Plc Fundamentals Summary
EVANSMED fundamental statistics | |
---|---|
Market cap | ₦366.17m |
Earnings (TTM) | -₦964.84m |
Revenue (TTM) | ₦3.34b |
0.0x
P/S Ratio0.0x
P/E RatioIs EVANSMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EVANSMED income statement (TTM) | |
---|---|
Revenue | ₦3.34b |
Cost of Revenue | ₦1.96b |
Gross Profit | ₦1.39b |
Other Expenses | ₦2.35b |
Earnings | -₦964.84m |
Last Reported Earnings
Dec 31, 2014
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did EVANSMED perform over the long term?
See historical performance and comparison